Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet regimen for controlling HIV infection. This medication unites three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to copy within the body, remarkably lowering the viral burden. For